Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 ...
More than 15 abstracts showcase how the Veracyte Diagnostics Platform is advancing urologic cancer care with decisions guided by Decipher Prostate and Bladder tests SOUTH SAN FRANCISCO, ...
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today more than 15 abstracts featuring its urology portfolio will be presented at the 2026 ASCO Genitourinary Cancers ...
The study "Reducing MRI Use in Organised Prostate Cancer Testing Using Blood-Based Biomarkers - the OPT Stockholm3 Study" ...
(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Himisha Beltran discussing how to read a ...
First men tested in landmark UK prostate cancer screening trial - Later this week, the UK National Screening Committee (UKNSC ...
Landmark UK prostate cancer screening trial begins with first men tested - Trial will inform future population-wide prostate ...
Medicare will now cover tests that screen for multiple types of cancer at once, under a new bipartisan law backed by Georgia ...
DeciBio Consulting has released the fourth edition of its Oncology Liquid Biopsy Market Report, offering updated global ...
March is Colorectal Cancer Awareness Month and an ideal time to focus on the third most common cancer in the U.S. Many people know the importance of ...
During Kidney Cancer Awareness Month, Dr. Eric Singer shares warning signs, risk factors and when younger adults should speak with a doctor about kidney health. March is Kidney Cancer Awareness Month, ...
Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results